Clinical Proteomics
Clinical Proteomics encompasses all aspects of translational proteomics. Special emphasis will be placed on the application of proteomic technology to all aspects of clinical research and molecular medicine. The journal is committed to rapid scientific review and timely publication of submitted manu...
Furkejuvvon:
| Searvvušdahkki: | |
|---|---|
| Eará dahkkit: | |
| Materiálatiipa: | Elektrovnnalaš Áigečála |
| Almmustuhtton: |
London :
BioMed Central : Imprint: BioMed Central.
|
| Fáttát: | |
| Liŋkkat: | Open Access |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|
MARC
| LEADER | 00000nas a22000005i 4500 | ||
|---|---|---|---|
| 001 | 1559-0275 | ||
| 003 | DE-He213 | ||
| 005 | 20180511105612.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 150723s||||||||xxkuu poo|||||| b|EN |d | ||
| 022 | |a 1559-0275 | ||
| 024 | 7 | |a 12014 |2 local | |
| 210 | 1 | 0 | |a Clin Proteom |
| 245 | 1 | 0 | |a Clinical Proteomics |h [electronic resource] / |c edited by Daniel W. Chan. |
| 264 | 1 | |a London : |b BioMed Central : |b Imprint: BioMed Central. | |
| 300 | |b online resource. | ||
| 520 | |a Clinical Proteomics encompasses all aspects of translational proteomics. Special emphasis will be placed on the application of proteomic technology to all aspects of clinical research and molecular medicine. The journal is committed to rapid scientific review and timely publication of submitted manuscripts. A key feature of Clinical Proteomics is its commitment to rapid scientific review and timely publication of submitted manuscripts. This is achieved receiving and processing submissions online. As molecular medicine moves beyond genomics to proteomics, the goal becomes the characterization of the cellular circuitry and the understanding of the impact of disease and therapy on cellular networks. Clinical Proteomics provides a scholarly forum for novel scientific research in the field of translational proteomics. The journal places special emphasis on the application of proteomic technology to all aspects of clinical research. A key feature is its commitment to rapid scientific review and timely publication of submitted manuscripts. | ||
| 650 | 0 | |a Life sciences. | |
| 650 | 0 | |a Biotechnology. | |
| 650 | 0 | |a Pathology. | |
| 650 | 0 | |a Proteomics. | |
| 650 | 0 | |a Cell biology. | |
| 650 | 1 | 4 | |a Life Sciences. |
| 650 | 2 | 4 | |a Cell Biology. |
| 650 | 2 | 4 | |a Pathology. |
| 650 | 2 | 4 | |a Biotechnology. |
| 650 | 2 | 4 | |a Proteomics. |
| 700 | 1 | |a Chan, Daniel W. |e editor. | |
| 710 | 2 | |a SpringerLink (Online service) | |
| 856 | 4 | 0 | |u http://link.springer.com/journal/12014 |z Open Access |
| 950 | |b Biomedical and Life Sciences | ||
| 999 | |c 189432 |d 189432 | ||